TRPV1-Dependent Autonomic Control in Diabetes
TRPV1 依赖性糖尿病自主控制
基本信息
- 批准号:8694847
- 负责人:
- 金额:$ 33.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-01 至 2019-03-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAgonistAutonomic DysfunctionAutonomic nervous systemBlood GlucoseBlood PressureBrainCellsClinicalConsciousDataDiabetes MellitusDiabetic mouseDrug TargetingElectrophysiology (science)Euglycemic ClampingGene ExpressionGene ProteinsGlucagonGluconeogenesisGlucoseGlucose ClampGlutamatesGlycogenGlycolysisGoalsHeart RateHepaticHomeostasisHypothalamic structureIn VitroInjection of therapeutic agentInsulinKnowledgeLaboratoriesLeadLiverLocationMaintenanceMeasuresModelingMonitorMusMuscleNeuronsNon-Insulin-Dependent Diabetes MellitusOutcomeOutputPeripheralPhysiologicalPlayPopulationPrevalencePropertyPublic HealthRegulationResearchRoleSerumSignal TransductionSiteSkeletal MuscleSliceStereotaxic TechniquesStructure of dorsomedial hypothalamic nucleusSynapsesSystemTelemetryTestingTherapeutic InterventionTissuesTracerVanilloidViralblood glucose regulationdiabetic patientglucose productionglucose uptakeglycemic controlhepatic gluconeogenesishigh riskimprovedin vivoinnovationmouse modelneurotransmissionneurotransmitter releasenovel strategiesoptogeneticsparaventricular nucleuspatch clamppostsynapticpresynapticprotein expressionpublic health relevancereceptorresearch studyresponseviral gene delivery
项目摘要
DESCRIPTION (provided by applicant): Systemic glucose homeostasis is substantially regulated by central autonomic circuits and there is a high risk of developing type 2 diabetes if autonomic dysfunction is present. Therefore, without a full understanding of the mechanisms governing the preautonomic neurons, there is a barrier to the understanding of the control of glycemic status. The overall long term goal of this proposal is to elucidate the fundamental relationship between central autonomic control and glucose homeostasis. The paraventricular nucleus (PVN) of the hypothalamus is a critical command center controlling autonomic outflow and, thereby, influencing glucose and energy homeostasis. Since impaired glucose homeostasis in diabetic patients involves central circuits controlling autonomic output, the immediate objective of this proposal is to identify transient receptor potential vanilloid type 1 (TRPV1)-dependent mechanisms involved in the regulation of preautonomic PVN neurons in the control of glycemic status using in vivo and in vitro approaches. The involvement of TRPV1 in diabetes has been established and recent studies from my laboratory have indicated that TRPV1 is a vital controller of preautonomic PVN neurons through increasing excitatory neurotransmitter release. Furthermore, this TRPV1- dependent excitation of liver-related PVN neurons was absent in a diabetic mouse model. Our preliminary observations demonstrate that activation of TRPV1 in the PVN lowers systemic blood glucose levels in control mice likely through increasing glucose uptake of the muscle and decreasing gluconeogenesis by the liver. These observations lead to the central hypothesis that preautonomic PVN neurons receive TRPV1-expressing inputs and these inputs are integrated into a coordinated autonomic output signal to generate an appropriate glycemic response. The proposed in vivo studies will determine the effect of TRPV1 activation in PVN circuits on autonomic endpoints. The effect of TRPV1 activation in PVN on glucose homeostasis will be determined using hyperinsulinemic-euglycemic clamp studies in conscious mice, and on blood pressure and heart rate using telemetry. Systems level studies using optogenetics will determine the effect of selective stimulation and inhibition of TRPV1 inputs on glucose homeostasis using TRPV1cre mice. Whole-cell, patch-clamp studies will reveal the cellular effects of activation and inhibition of TRPV1 inputs on PVN neurons, and we will identify preautonomic neuronal populations in the PVN regulated by TRPV1-expressing projections. Furthermore, the effect of TRPV1 activation on neurotransmission will be determined using photostimulation in TRPV1cre mice. These studies will define the role of central TRPV1 action on whole body glucose homeostasis through preautonomic PVN neurons, and will differentiate the importance of pre- and postsynaptic locations of TRPV1 on this system. The outcomes of the proposed studies hold the promise of opening innovative clinical strategies and drug targets for the improvement of glycemic status in diabetic patients via autonomic control.
描述(申请人提供):全身性葡萄糖稳态在很大程度上受中枢自主神经回路的调节,如果存在自主神经功能障碍,则发展为2型糖尿病的风险很高。因此,如果不完全了解自主神经前神经元的调控机制,就会阻碍对血糖状态控制的理解。这项建议的总体长期目标是阐明中枢自主神经控制和血糖稳态之间的基本关系。下丘脑室旁核(PVN)是控制自主神经流出的重要指挥中心,从而影响血糖和能量平衡。由于糖尿病患者糖平衡受损涉及控制自主神经输出的中枢回路,本研究的直接目标是利用体内和体外方法确定瞬时受体电位香草样物质1型(TRPV1)依赖的机制,参与调节自主神经前PVN神经元的血糖状态。TRPV1在糖尿病中的作用已得到证实,最近我实验室的研究表明,TRPV1通过增加兴奋性神经递质的释放,是自主神经前PVN神经元的重要控制器。此外,这种依赖于TRPV1的肝脏相关PVN神经元的兴奋在糖尿病小鼠模型中是不存在的。我们的初步观察表明,PVN中TRPV1的激活可能通过增加肌肉对葡萄糖的摄取和减少肝脏的糖异生来降低对照组小鼠的全身血糖水平。这些观察结果导致了一个中心假设,即PVN前自主神经接收到TRPV1表达的输入,这些输入被整合到一个协调的自主输出信号中,以产生适当的血糖反应。拟议的活体研究将确定PVN回路中TRPV1激活对自主神经终点的影响。TRPV1在PVN中的激活对葡萄糖稳态的影响将通过清醒小鼠的高胰岛素-正常血糖钳夹研究来确定,并将通过遥测来确定对血压和心率的影响。利用光遗传学进行的系统水平研究将利用TRPV1cre小鼠确定选择性刺激和抑制TRPV1输入对葡萄糖稳态的影响。全细胞膜片钳研究将揭示TRPV1的激活和抑制对PVN神经元的细胞影响,我们将确定由TRPV1表达的投射调节的PVN中的自主神经前神经元群。此外,将利用光刺激在TRPV1cre小鼠身上确定TRPV1激活对神经传递的影响。这些研究将确定中枢TRPV1通过自主神经前PVN神经元对全身血糖稳态的作用,并将区分TRPV1突触前和突触后位置在该系统中的重要性。拟议研究的结果有望开启创新的临床策略和药物靶点,通过自主神经控制改善糖尿病患者的血糖状况。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrea Zsombok其他文献
Andrea Zsombok的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrea Zsombok', 18)}}的其他基金
Impact of estradiol on the central regulation of glucose homeostasis and subsequent implications for hippocampal function.
雌二醇对葡萄糖稳态中枢调节的影响以及随后对海马功能的影响。
- 批准号:
10334235 - 财政年份:2022
- 资助金额:
$ 33.49万 - 项目类别:
Impact of estradiol on the central regulation of glucose homeostasis and subsequent implications for hippocampal function.
雌二醇对葡萄糖稳态中枢调节的影响以及随后对海马功能的影响。
- 批准号:
10579251 - 财政年份:2022
- 资助金额:
$ 33.49万 - 项目类别:
TRPV1-Dependent Autonomic Control in Diabetes
TRPV1 依赖性糖尿病自主控制
- 批准号:
9238766 - 财政年份:2014
- 资助金额:
$ 33.49万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 33.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 33.49万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 33.49万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 33.49万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 33.49万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 33.49万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 33.49万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 33.49万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 33.49万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 33.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)